Falk Catalyst Research Award Program
Limited submissionForecasted
Falk Catalyst Research Award Program supports biomedical research teams with seed funding to overcome therapeutic roadblocks and advance promising innovations toward clinical practice in the near term.
Browse similar grants
Funder: Health Resources in Action
Due Dates (Anticipated): June 2027 (Application deadline)
Funding Amounts: Up to $350,000 over 1–2 years, including indirect costs
Summary: Seed funding for high-risk, high-reward biomedical research that overcomes therapeutic roadblocks and can reach clinical practice in the near term.
Key Information: Applications require nomination by an invited institution and a full-time independent faculty administrative PI.
Description
The Falk Catalyst Research Award supports translational biomedical research addressing critical scientific and therapeutic roadblocks. Health Resources in Action administers the program for the Dr. Ralph and Marian Falk Medical Research Trust, with Bank of America, N.A., serving as trustee. The Trust seeks to improve treatments and ultimately find cures for diseases without a definite cure.
Projects must address biological markers of disease activity or progression, targets for therapeutic intervention, or therapeutic agents that disrupt, arrest, or prevent disease. Catalyst funding supports preliminary work, teams, tools, techniques, and management infrastructure needed to demonstrate scientific promise and prepare for a subsequent Transformational Award. All translational stages are eligible, from early preclinical development through investigator-initiated trials, with an emphasis on innovations transferable to clinical practice in the near term.
